Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$2.96 - $36.67 $194,125 - $2.4 Million
-65,583 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$31.5 - $42.5 $1.51 Million - $2.04 Million
-47,883 Reduced 42.2%
65,583 $2.21 Million
Q1 2021

May 12, 2021

BUY
$25.01 - $40.24 $1.21 Million - $1.95 Million
48,466 Added 74.56%
113,466 $3.89 Million
Q4 2020

Feb 16, 2021

BUY
$28.66 - $46.79 $1.86 Million - $3.04 Million
65,000 New
65,000 $2.37 Million

Others Institutions Holding FBRX

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $117M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.